{"id":1396,"text":"Despite increasing recognition of potential untoward interactions between herbal products and conventional medications, a standard system for prospective assessment of these interactions remains elusive.","label":[[73,89,"Herb name"],[94,118,"Drug"]],"Comments":[]}
{"id":1397,"text":"This information gap was addressed by evaluating the drug interaction liability of the model herbal product milk thistle (Silybum marianum) with the CYP3A probe substrate midazolam.","label":[[83,139,"Herb name"],[146,180,"Drug"],[149,154,"Parameter"]],"Comments":[]}
{"id":1398,"text":"The inhibitory effects of commercially available milk thistle extracts and isolated constituents on midazolam 1′-hydroxylation were screened using human liver and intestinal microsomes.","label":[[49,96,"Herb name"],[100,109,"Drug"],[100,126,"Parameter"]],"Comments":[]}
{"id":1399,"text":"Relative to vehicle, the extract silymarin and constituents silybin A, isosilybin A, isosilybin B, and silychristin at 100 μM demonstrated >50% inhibition of CYP3A activity with at least one microsomal preparation, prompting IC","label":[[21,115,"Herb name"],[119,125,"Amount"],[139,143,"Amount"],[158,163,"Target"],[158,172,"Parameter"]],"Comments":[]}
